Joyce Tung

Joyce Tung, holding the position of Vice President of Research at 23andMe, has been instrumental in the company's growth and evolution. Her responsibilities encompass the full spectrum of 23andMe's human genetics research program, overseeing the data of over ten million consented participants. Tung's tenure has been dotted with pivotal moments, from the inception of the consumer product to numerous scientific publications and collaborations.

Undeniably, one of Tung's significant contributions has been her role in securing FDA authorization for 23andMe's genetic reports. This accomplishment reflects her ability to navigate complex regulatory environments while championing the importance of genetic research for the general public. The launch of the therapeutics division, another milestone under her leadership, underscores her commitment to leveraging genetic data for advancements in medical treatment.

Prior to her professional achievements at 23andMe, Tung's academic pursuits laid a strong foundation for her current role. She earned her Ph.D. in Genetics from the University of California, San Francisco, during which time she was recognized as a National Science Foundation graduate research fellow. Subsequently, she honed her research skills as a postdoctoral fellow at Stanford University. These experiences have undoubtedly shaped Tung's approach to her work, emphasizing rigorous scientific inquiry and a dedication to improving human health through genetic understanding.